BACKGROUND: Acute traumatic coagulopathy affects 20% to 30% of trauma patients, but the extensive collinearity of the coagulation cascade complicates attempts to clarify global clotting factor dysfunction. This study aimed to characterize phenotypes of clotting factor dysfunction and their contributions to mortality after major trauma. METHODS: This prospective cohort study examines all adult trauma patients of the highest activation level presenting to San Francisco General Hospital between February 2005 and February 2015. Factors II, V, VII, VIII, IX, and X and protein C activity on admission and mortality status at 28 days were assessed. Predictors of 28-day mortality in univariate analysis were included in multiple logistic regression controlling for traumatic brain injury (TBI), acidosis, age, and mechanism of injury. Principal component analysis was utilized to identify phenotypic coagulation. RESULTS: Complete coagulation factor data were available for 876 (61%) of 1,429 patients. In multiple logistic regression, factors V (odds ratio [OR], 0.86; 95% confidence interval [CI], 0.76-0.97), VIII (OR, 0.97; 95% CI, 0.95-0.99), and X (OR, 0.79; 95% CI, 0.68-0.92) and protein C (OR, 1.17; 95% CI, 1.05-1.30) significantly predicted 28-day mortality after controlling for age, base deficit, mechanism of injury, and TBI. Principal component analysis identified two significant principal components (Phenotypes 1 and 2) that accounted for 66.3% of the total variance. Phenotype 1 (factors II, VII, IX, and X and protein C abnormalities) explained 49.3% and was associated with increased injury, coagulopathy, TBI, and mortality. Phenotype 2 (factors V and VIII abnormalities) explained 17.0% and was associated with increased coagulopathy, blunt injury, and mortality. Only Phenotype 2 remained significantly associated with 28-day mortality in multiple logistic regression. CONCLUSIONS: Principal component analysis identified two distinct phenotypes within the entirety of global clotting factor abnormalities, and these findings substantiate the crucial association of factors V and VIII on mortality following trauma. This may be the first step toward identifying unique phenotypes after injury and personalizing hemostatic resuscitation. LEVEL OF EVIDENCE: Prognostic study, level III.
BACKGROUND: Acute traumatic coagulopathy affects 20% to 30% of traumapatients, but the extensive collinearity of the coagulation cascade complicates attempts to clarify global clotting factor dysfunction. This study aimed to characterize phenotypes of clotting factor dysfunction and their contributions to mortality after major trauma. METHODS: This prospective cohort study examines all adult traumapatients of the highest activation level presenting to San Francisco General Hospital between February 2005 and February 2015. Factors II, V, VII, VIII, IX, and X and protein C activity on admission and mortality status at 28 days were assessed. Predictors of 28-day mortality in univariate analysis were included in multiple logistic regression controlling for traumatic brain injury (TBI), acidosis, age, and mechanism of injury. Principal component analysis was utilized to identify phenotypic coagulation. RESULTS: Complete coagulation factor data were available for 876 (61%) of 1,429 patients. In multiple logistic regression, factors V (odds ratio [OR], 0.86; 95% confidence interval [CI], 0.76-0.97), VIII (OR, 0.97; 95% CI, 0.95-0.99), and X (OR, 0.79; 95% CI, 0.68-0.92) and protein C (OR, 1.17; 95% CI, 1.05-1.30) significantly predicted 28-day mortality after controlling for age, base deficit, mechanism of injury, and TBI. Principal component analysis identified two significant principal components (Phenotypes 1 and 2) that accounted for 66.3% of the total variance. Phenotype 1 (factors II, VII, IX, and X and protein C abnormalities) explained 49.3% and was associated with increased injury, coagulopathy, TBI, and mortality. Phenotype 2 (factors V and VIII abnormalities) explained 17.0% and was associated with increased coagulopathy, blunt injury, and mortality. Only Phenotype 2 remained significantly associated with 28-day mortality in multiple logistic regression. CONCLUSIONS: Principal component analysis identified two distinct phenotypes within the entirety of global clotting factor abnormalities, and these findings substantiate the crucial association of factors V and VIII on mortality following trauma. This may be the first step toward identifying unique phenotypes after injury and personalizing hemostatic resuscitation. LEVEL OF EVIDENCE: Prognostic study, level III.
Authors: Geoffrey P Dobson; Hayley L Letson; Rajiv Sharma; Forest R Sheppard; Andrew P Cap Journal: J Trauma Acute Care Surg Date: 2015-08 Impact factor: 3.313
Authors: Carl J Hauser; Kenneth Boffard; Richard Dutton; Gordon R Bernard; Martin A Croce; John B Holcomb; Ari Leppaniemi; Michael Parr; Jean-Louis Vincent; Bartholomew J Tortella; Jeannett Dimsits; Bertil Bouillon Journal: J Trauma Date: 2010-09
Authors: Matthew E Kutcher; Benjamin M Howard; Jason L Sperry; Alan E Hubbard; Anna L Decker; Joseph Cuschieri; Joseph P Minei; Ernest E Moore; Bernard H Brownstein; Ronald V Maier; Mitchell Jay Cohen Journal: J Trauma Acute Care Surg Date: 2015-03 Impact factor: 3.313
Authors: Christopher B Allard; Sandro Scarpelini; Shawn G Rhind; Andrew J Baker; Pang N Shek; Homer Tien; Michael Fernando; Lorraine Tremblay; Laurie J Morrison; Ruxandra Pinto; Sandro B Rizoli Journal: J Trauma Date: 2009-11
Authors: Bryce A Kerlin; S Betty Yan; Berend H Isermann; John T Brandt; Rashmi Sood; Bruce R Basson; David E Joyce; Hartmut Weiler; Jean-Francois Dhainaut Journal: Blood Date: 2003-07-17 Impact factor: 22.113
Authors: Karim Brohi; Mitchell J Cohen; Michael T Ganter; Michael A Matthay; Robert C Mackersie; Jean-François Pittet Journal: Ann Surg Date: 2007-05 Impact factor: 12.969
Authors: Hai Po H Liang; Edward J Kerschen; Sreemanti Basu; Irene Hernandez; Mark Zogg; Shuang Jia; Martin J Hessner; Raffaella Toso; Alireza R Rezaie; José A Fernández; Rodney M Camire; Wolfram Ruf; John H Griffin; Hartmut Weiler Journal: Blood Date: 2015-09-04 Impact factor: 22.113
Authors: Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Julia R Coleman; Arthur Colvis; Arsen Ghasabyan; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Angela Sauaia Journal: J Trauma Acute Care Surg Date: 2019-09 Impact factor: 3.313
Authors: Joshua J Sumislawski; S Ariane Christie; Lucy Z Kornblith; Gregory R Stettler; Geoffrey R Nunns; Hunter B Moore; Ernest E Moore; Christopher C Silliman; Angela Sauaia; Rachael A Callcut; Mitchell Jay Cohen Journal: Am J Surg Date: 2019-01-23 Impact factor: 2.565
Authors: Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Jim Chandler; Erik Peltz; Christopher C Silliman; Anirban Banerjee; Angela Sauaia Journal: J Surg Res Date: 2018-04-11 Impact factor: 2.192
Authors: Manuel Burggraf; Christina Polan; Heinz-Lothar Meyer; Roman Maximilian Müller; Felix Reinecke; Marcel Dudda; Max Daniel Kauther Journal: Biomed Res Int Date: 2020-12-30 Impact factor: 3.411
Authors: Sascha Halvachizadeh; Larissa Baradaran; Paolo Cinelli; Roman Pfeifer; Kai Sprengel; Hans-Christoph Pape Journal: PLoS One Date: 2020-01-24 Impact factor: 3.240